Valproic Acid and Cognitive Decline in HIV Patients
Author Information
Author(s): Lucette A. Cysique, Paul Maruff, Bruce J. Brew
Primary Institution: University of California at San Diego
Hypothesis
Does valproic acid (VPA) have a negative effect on cognitive functions in advanced HIV-infected individuals?
Conclusion
The study suggests that valproic acid may be associated with cognitive decline in advanced HIV-infected individuals.
Supporting Evidence
- Individuals on valproic acid showed greater cognitive impairment over time.
- The study controlled for factors like HIV disease severity and depressive symptoms.
- Participants on valproic acid had a higher prevalence of past HIV-related CNS diseases.
Takeaway
This study found that taking valproic acid might make it harder for people with advanced HIV to think clearly.
Methodology
The study used a longitudinal observational design with a cohort of HIV-infected individuals assessed over time.
Potential Biases
Potential bias due to non-randomized group assignment and the small number of subjects.
Limitations
The small sample size and non-randomization may limit the generalizability of the results.
Participant Demographics
Participants included advanced HIV-infected individuals, with a mean age of approximately 50 years.
Statistical Information
P-Value
p<0.005
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website